# ACON Bios Investors, L.P. — Form D

ACON Bios Investors, L.P. of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-21. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-12-21
- Form: D
- Accession: 0001567619-18-008497
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $25.0M
- Investors: 2
- Date of first sale: 2018-12-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-328782

## Issuer

- Name: ACON Bios Investors, L.P.
- CIK: 0001761493
- Entity type: Limited Partnership
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Incorporated: 2018
- Address: 1133 CONNECTICUT AVENUE, N.W., SUITE 700, WASHINGTON, DC, 20036
- Phone: 202-454-1100

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Teresa Y Bernstein | Executive Officer | Washington D.C., DC |
| Jose Knoell | Executive Officer | Washington, DC |
| KWAME Y LEWIS | Executive Officer | Washington, DC |
| N/A ACON Bios GenPar, L.L.C. | Promoter | Washington, DC |

## More

- [CIK 1761493 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1761493&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-18-008497.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.